Posted in | News | Packaging | Titanium

Kemira and Rockwood Establish Titanium Dioxide Pigments Joint Venture

Kemira Oyj and Rockwood Holdings Inc. have agreed to form a joint venture that includes both parties´ titanium dioxide businesses and the functional additives business owned by Rockwood. The transaction values Kemira’s TiO2 business in excess of EUR 250 million and will result in a small capital gain for Kemira. In addition, the transaction will have a positive cash flow effect and reduce Kemira´s net debt by appr. EUR 120 million. The deal is subject to approval by the competition authorities and is expected to close during Q3 in 2008.

The new joint venture will include Rockwood´s titanium dioxide pigments and functional additives businesses, including its production facilities in Duisburg, Germany and Kemira´s titanium dioxide business, including Kemira´s titanium dioxide plant in Pori and Kemira´s technical research center specializing in TiO2 products in Oberhausen, Germany and its US subsidiary, Kemira Specialty, Inc. Kemira´s TiO2 business had a turnover of appr. EUR 230 million in 2007 and operative EBITDA of slightly less than 14 %.

The new specialty titanium dioxide company will be headquartered in Germany and had a pro forma turnover of appr. EUR 560 million in 2007. The new company will have a yearly production capacity of around 240 000 tons of titanium dioxide and it will employ around 1 700 employees. Rockwood will own 61 % and Kemira 39 % of the new joint venture.

“This joint venture is an excellent way of developing the value of our titanium dioxide business and it will provide a good platform for synergy creation e.g. through better capacity utilization” says Harri Kerminen, CEO of Kemira Group. “The new company will be a highly specialized titanium dioxide producer with strong market positions in global niche market segments. It will be the leading provider of titanium dioxide pigments for textile, packaging ink and cosmetics industries worldwide”, Kerminen continues.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.